These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8063392)

  • 1. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys.
    Kwaga JK; Allan BJ; van der Hurk JV; Seida H; Potter AA
    Infect Immun; 1994 Sep; 62(9):3766-72. PubMed ID: 8063392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
    Nagano T; Kitahara R; Nagai S
    Microbiol Immunol; 2012 Sep; 56(9):605-12. PubMed ID: 22708916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys.
    La Ragione RM; Woodward MJ; Kumar M; Rodenberg J; Fan H; Wales AD; Karaca K
    Avian Dis; 2013 Jun; 57(2):273-9. PubMed ID: 24689185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
    Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
    PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian pathogenic Escherichia coli (APEC).
    Dho-Moulin M; Fairbrother JM
    Vet Res; 1999; 30(2-3):299-316. PubMed ID: 10367360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
    Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
    Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.
    Kariyawasam S; Wilkie BN; Gyles CL
    Avian Dis; 2004; 48(2):287-99. PubMed ID: 15283416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Iss as a potential vaccine for avian colibacillosis.
    Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
    Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pathologic findings of Escherichia coli infection in birds.
    Cheville NF; Arp LH
    J Am Vet Med Assoc; 1978 Sep; 173(5 Pt 2):584-7. PubMed ID: 359516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens.
    Roland K; Curtiss R; Sizemore D
    Avian Dis; 1999; 43(3):429-41. PubMed ID: 10494411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of an avian pathogenic Escherichia coli strain due to a mutation in the rpsL gene.
    Amoako KK; Prysliak T; Potter AA; Collinson SK; Kay WW; Allan BJ
    Avian Dis; 2004; 48(1):19-25. PubMed ID: 15077794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live-attenuated vaccine candidates.
    Holden KM; Browning GF; Noormohammadi AH; Markham P; Marenda MS
    Vet Microbiol; 2014 Oct; 173(3-4):289-98. PubMed ID: 25205199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate.
    Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X
    Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers.
    Peighambari SM; Hunter DB; Shewen PE; Gyles CL
    Avian Dis; 2002; 46(2):287-97. PubMed ID: 12061637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Escherichia coli isolated from cases of avian colibacillosis.
    Allan BJ; van den Hurk JV; Potter AA
    Can J Vet Res; 1993 Jul; 57(3):146-51. PubMed ID: 8358674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of avian Escherichia coli cya crp mutants.
    Peighambari SM; Gyles CL
    Avian Dis; 1998; 42(4):698-710. PubMed ID: 9876838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli.
    Melamed D; Leitner G; Heller ED
    Avian Dis; 1991; 35(1):17-22. PubMed ID: 2029251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts.
    Dziva F; Stevens MP
    Avian Pathol; 2008 Aug; 37(4):355-66. PubMed ID: 18622850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of vaccination of broiler chickens against Escherichia coli with live attenuated vaccine on general properties of E. coli population, IBV vaccination efficiency, and production parameters-a field experiment.
    Śmiałek M; Kowalczyk J; Koncicki A
    Poult Sci; 2020 Nov; 99(11):5452-5460. PubMed ID: 33142462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
    Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.